Oxford Nanopore Technologies PLC 2021 AR2
The report highlights Oxford Nanopore Technologies' exceptional financial and operational progress in 2021, including its successful IPO on the London Stock Exchange. The company achieved a 94% increase in Life Science Research Tools (LSRT) revenue to #127.0 million, with total revenue reaching #133.7 million. Key technological milestones included the launch of Q20+ chemistry, enabling raw read accuracy of greater than 99%, and the development of the PromethION 2 device. Additionally, the company expanded its global headcount to 803 employees and formally defined its ESG material topics, aligning with the UN Sustainable Development Goals.
Company: Oxford Nanopore Technologies PLC
Sector: Professional & technical services
Country: United Kingdom
Year: 2021
Type: AR2
Pages: 104
Oxford Nanopore Technologies PLC
The report highlights Oxford Nanopore Technologies' exceptional financial and operational progress in 2021, including its successful IPO on the London Stock Exchange. The company achieved a 94% increase in Life Science Research Tools (LSRT) revenue to #127.0 million, with total revenue reaching #133.7 million. Key technological milestones included the launch of Q20+ chemistry, enabling raw read accuracy of greater than 99%, and the development of the PromethION 2 device. Additionally, the company expanded its global headcount to 803 employees and formally defined its ESG material topics, aligning with the UN Sustainable Development Goals.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Jan 1, 2021 - Dec 31, 2021
Fiscal Year
2021
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Women on Board
Women in Management
Employees